KMDA
Price
$7.72
Change
-$0.06 (-0.77%)
Updated
Jul 25 closing price
Capitalization
306.49M
18 days until earnings call
LFCR
Price
$7.43
Change
+$0.08 (+1.09%)
Updated
Jul 25 closing price
Capitalization
176.87M
32 days until earnings call
Interact to see
Advertisement

KMDA vs LFCR

Header iconKMDA vs LFCR Comparison
Open Charts KMDA vs LFCRBanner chart's image
Kamada
Price$7.72
Change-$0.06 (-0.77%)
Volume$18.11K
Capitalization306.49M
Lifecore Biomedical
Price$7.43
Change+$0.08 (+1.09%)
Volume$111.73K
Capitalization176.87M
KMDA vs LFCR Comparison Chart in %
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. LFCR commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and LFCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (KMDA: $7.72 vs. LFCR: $7.43)
Brand notoriety: KMDA and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 26% vs. LFCR: 51%
Market capitalization -- KMDA: $306.49M vs. LFCR: $176.87M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, KMDA is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish while LFCR’s TA Score has 3 bullish TA indicator(s).

  • KMDA’s TA Score: 4 bullish, 4 bearish.
  • LFCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than LFCR.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а +3.62% price change this week, while LFCR (@Pharmaceuticals: Other) price change was -0.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

KMDA is expected to report earnings on Nov 12, 2025.

LFCR is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than LFCR($177M). KMDA YTD gains are higher at: 30.397 vs. LFCR (0.000). KMDA has higher annual earnings (EBITDA): 22.4M vs. LFCR (-22.64M). KMDA has more cash in the bank: 55.6M vs. LFCR (4.22M). KMDA has less debt than LFCR: KMDA (8.82M) vs LFCR (157M). LFCR has higher revenues than KMDA: LFCR (188M) vs KMDA (143M).
KMDALFCRKMDA / LFCR
Capitalization306M177M173%
EBITDA22.4M-22.64M-99%
Gain YTD30.3970.000-
P/E Ratio37.43N/A-
Revenue143M188M76%
Total Cash55.6M4.22M1,317%
Total Debt8.82M157M6%
FUNDAMENTALS RATINGS
KMDA vs LFCR: Fundamental Ratings
KMDA
LFCR
OUTLOOK RATING
1..100
7152
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
80100
PRICE GROWTH RATING
1..100
4852
P/E GROWTH RATING
1..100
455
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (71) in the Biotechnology industry is in the same range as LFCR (94) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

KMDA's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

KMDA's SMR Rating (80) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

KMDA's Price Growth Rating (48) in the Biotechnology industry is in the same range as LFCR (52) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is somewhat better than the same rating for KMDA (45) in the Biotechnology industry. This means that LFCR’s stock grew somewhat faster than KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDALFCR
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KWGPF0.05N/A
N/A
KWG GROUP HLDGS LTD.
CNGKY9.40N/A
N/A
CK Asset Hldgs Ltd
NLIBF0.27N/A
N/A
NOA LITHIUM BRINES INC
FBBPF3.50-0.18
-4.97%
FIBRA PROLOGIS REIT CTFS
AAUGF0.03N/A
-10.71%
AERO ENERGY LTD.

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.09%
SHPH - LFCR
31%
Poorly correlated
+1.04%
AMRX - LFCR
28%
Poorly correlated
+0.75%
TLRY - LFCR
27%
Poorly correlated
-2.03%
ALKS - LFCR
26%
Poorly correlated
-1.51%
KMDA - LFCR
26%
Poorly correlated
-0.77%
More